Suchergebnisse - "Shiu, Kai-Keen"

PubPharm (48)

1

Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary

enthalten in: Cancer medicine | 2024

von Harvey, S. | Stares, M. | Scott, J. | +11

2

Genetic and immune landscape evolution in MMR-deficient colorectal cancer

enthalten in: The Journal of pathology | 2024

von Challoner, B. | Woolston, A. | Lau, D. | +38

3

Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid Biopsies

enthalten in: Cancers | 2024

von Mahmood, U. | Muhamad Faizul, E. | Howlett, S. | +5

4

Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary

enthalten in: Cancer Medicine | 2024

von Harvey, S. | Stares, M. | Scott, J. | +11

5

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859) : a multicentre, randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Rha, S. | Oh, D. | Yañez, P. | +121

6

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

enthalten in: Nature communications | 2023

von Hasan, A. | Cremaschi, P. | Wetterskog, D. | +121

7

Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer

enthalten in: Cancer science | 2023

von Yoshino, T. | Andre, T. | Kim, T. | +17

8

The immunomodulatory role of IDO1-Kynurenine-NAD+ pathway in switching cold tumor microenvironment in PDAC

enthalten in: Frontiers in oncology | 2023

von Anu, R. | Shiu, K. | Khan, K.

9

Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer

enthalten in: Journal of gastrointestinal oncology | 2022

von Morelli, C. | Formica, V. | Patrikidou, A. | +9

10

Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy - Authors' reply

enthalten in: The Lancet. Oncology | 2022

von André, T. | Diaz, L. | Shiu, K.

CommentOn: Lancet Oncol. 2022 May;23(5):659-670. - PMID 35427471

1
2
3
4
5
Nächster »
[5]